Navigation Links
CCA Industries, Inc. Declares Its Seventeenth Consecutive Dividend
Date:7/7/2008

EAST RUTHERFORD, N.J., July 7 /PRNewswire-FirstCall/ -- CCA Industries, Inc. (Amex: CAW) declared today a dividend for the third quarter of $0.11 per share to all shareholders of record as of August 1, 2008, payable on September 1, 2008.

Revenues for the second quarter ending May 31, 2008 were $17,389,985. Net income was $790,692 and earnings per share were $0.11 fully diluted versus revenues of $18,457,562, net income of $1,292,921 and earnings per share of $0.18 fully diluted for the second quarter of 2007.

Revenue for the six months ended May 31, 2008 were $31,261,025, net income was $1,134,375 and earnings per share were $0.16 fully diluted, compared to revenues of $32,285,140, net income of $1,765,669 and earnings per share of $0.25 fully diluted for the same period in 2007.

"Net sales and earnings were somewhat lower in both the second quarter and for the first six (6) months of the 2008 fiscal year. The aforementioned was primarily due to a 10% sales reduction of the Company's Mega-T weight loss brand. The Company attributes the sales decline to the heavily advertised former prescriptive diet aid by a leading pharmaceutical company. CCA will be introducing several new unique diet aids in their fourth quarter in order to offset the recent sales decline in their Mega-T diet aid sales. In addition, the Company will be introducing a number of new SKUs to their other brands also in the upcoming third and fourth quarters," stated Dunnan Edell, President of CCA.

CCA also announces today that it has been added to the Russell Microcap Index after the Russell Investment Group reconstituted its comprehensive set of U.S. and global equity indexes on June 27, 2008. "Russell is an industry leader for stock indexes, and we are pleased to be included in their Microcap Index," said Dunnan Edell. "We expect our inclusion will generate greater interest in our stock among institutional investors."

CCA Industries, Inc. manufactures and markets health and beauty aids, each under its individual brand name. The products include, principally, "Plus+White" toothpastes and teeth whiteners, "Mega-T" Green Tea diet supplements, "Mega-T" Green Tea gum and mint products, "Bikini Zone" medicated topicals and shave gels, "Nutra Nail" nail care treatments, "Scar Zone" scar treatment products, "Sudden Change" anti-aging skin care products, "Parfume de Vanille" fragrances, "Solar Sense" sun protection products, "Hair Off" hair removal and depilatory products, and "Wash 'N Curl" shampoos and conditioners.

Statements contained in the news release that are not historical facts are forward looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, which would cause actual results to differ materially from estimated results. Such risks and uncertainties are detailed in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE CCA Industries, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CCA Industries, Inc. Announces First Quarter Results
2. Hillenbrand Industries, Inc. Announces Expiration and Final Results of its Previously Announced Any and All Cash Tender Offer for its 4.50 Percent Senior Notes Due 2009
3. Hillenbrand Industries, Inc. Announces Pricing of Its Pending Any and All Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009
4. Hillenbrand Industries, Inc. Announces Early Tender Results of its Pending Any and All Cash Tender Offer for its 4.50 Percent Senior Notes Due 2009
5. Herley Industries, Inc. Second Quarter Earnings Release and Conference Call Notice
6. Hillenbrand Industries, Inc. Announces Any and All Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009
7. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
8. Herley Industries, Inc. Receives a $5 Million Award from EDO for Electronic Components for IEDs
9. Lilly Declares Third-Quarter Dividend
10. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
11. Governor Bredesen Declares Tennessee Patient Advocacy Day to Promote Healthcare Accessibility for All
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 19, 2017 , ... Aerolib Healthcare Solutions ... Clinical and Regulatory education for Physicians, Physician Advisors, Case managers, Utilization Review ... of Disease Specific Documentation Improvement. , The Aerolib Learning Management System is ...
(Date:1/19/2017)... ... 19, 2017 , ... With the cold weather here, many people will have to clear snow ... clearing large amounts of snow, but they can be dangerous when used incorrectly. That’s why ... Commission for the proper use of snow blowers:, , When removing ...
(Date:1/19/2017)... ... January 19, 2017 , ... WhoHaha , a digital media company ... Heart Association (AHA) to produce a three-part video series that uses humor to highlight ... of the launch of AHA’s Healthy For Good™ movement, which is designed to inspire ...
(Date:1/19/2017)... ... January 19, 2017 , ... WholeHealth is ... year. Drs. Alexander Paziotopoulos, Andrew Petersen and Trish Henrie-Barrus will be present Saturday ... clinic’s leading recovery program. , “We know it’s easy to get carried ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... recently provided a new $11,250,000 senior credit facility to Sunrise, Florida-based Management Health ... facility were used to facilitate a recapitalization of MedPro led by Harren Equity ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... point-of-care blood analysis instruments and consumables for the medical ... to discuss its financial results for the third quarter ... will be at 4:15 p.m. ET on Thursday, January ... the third quarter fiscal year 2017 after the market ...
(Date:1/19/2017)... January 19, 2017 Shire plc ... the U.S. Food and Drug Administration (FDA) has acknowledged ... Drug Application (NDA) for SHP465, a long-acting, triple-bead, mixed ... potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA ... June 20, 2017, the designated Prescription Drug User Fee ...
(Date:1/19/2017)... 19, 2017 While various ... about reducing the FDA,s regulatory strictness as a ... medical drug industry, many of the leading biotech ... trials and development of advanced drug treatments and ... recent developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology: